Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation
Clear cell renal cell carcinoma (ccRCC) represents the most common subtype of renal cell carcinoma (RCC). In spite of recent advances in the treatment armamentarium and outcomes with the combined use of immune checkpoint and angiogenesis inhibitors, prediction of responses and selection of patients...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Codon Publications
2020-06-01
|
| Series: | Journal of Kidney Cancer and VHL |
| Online Access: | https://www.jkcvhl.com/index.php/jkcvhl/article/view/135 |